Update on proteasome inhibitors in multiple myeloma
Richardson, P.G.
Clinical Advances in Hematology and Oncology H&o 12(3): 179-181
2014
ISSN/ISBN: 1543-0790 PMID: 24927266 Document Number: 673794
Document emailed within 1 workday
Related Documents
Kanagasabaphy, P.; Morgan, G.J.; Davies, F.E. 2007: Proteasome inhibition and multiple myeloma Current Opinion in Investigational Drugs 8(6): 447-451Murakami, H.; Saito, T.; Handa, H. 2013: I. Proteasome inhibitor for treatment of multiple myeloma Gan to Kagaku Ryoho. Cancer and ChemoTherapy 40(5): 583-588
Di Napoli, M.; McLaughlin, B. 2005: The ubiquitin-proteasome system as a drug target in cerebrovascular disease: therapeutic potential of proteasome inhibitors Current Opinion in Investigational Drugs 6(7): 686-699
2009: Treatment of multiple myeloma: 2009 update Prescrire international 18(104): 263-266
Giuliani, N.; Colla, S.; Rizzoli, V. 2004: Update on the pathogenesis of osteolysis in multiple myeloma patients Acta Bio-Medica: Atenei Parmensis 75(3): 143-152
Mendez-Lopez, M.; Sutter, T.; Driessen, C.; Besse, L. 2019: HIV protease inhibitors for the treatment of multiple myeloma Clinical Advances in Hematology and Oncology: H&o 17(11): 615-623
Stegmann, D.A. 2016: Histone deacetylase inhibitors: new synergistic third-line option in multiple myeloma Medizinische Monatsschrift für Pharmazeuten 39(4): 142-147
Weber, D.M. 2003: Strategies in treating newly diagnosed or untreated multiple myeloma patients. from the Multiple Myeloma Research Foundation Oncology 17(6): 765-767
Saeki, Y.; Fukunaga, K.; Tanaka, K. 2010: Proteasome inhibitors Nihon Rinsho. Japanese Journal of Clinical Medicine 68(10): 1818-1822
Harding, C.V.; France, J.; Song, R.; Farah, J.M.; Chatterjee, S.; Iqbal, M.; Siman, R. 1995: Novel dipeptide aldehydes are proteasome inhibitors and block the MHC-I antigen-processing pathway Journal of Immunology 155(4): 1767-1775
Pasqualetti, P.; Casale, R.; Collacciani, A.; Colantonio, D. 1989: Evaluation of a morphologic staging method (myeloma progression score) in multiple myeloma Medicina 9(3): 280-282
Barlogie, B.; Alexanian, R. 1989: Second International Workshop on Myeloma: advances in biology and therapy of multiple myeloma Cancer Research 49(24 Pt 1): 7172-7175
Milligan, S.A.; Nopajaroonsri, C. 2001: Inhibition of NF-kappa B with proteasome inhibitors enhances apoptosis in human lung adenocarcinoma cells in vitro Anticancer Research 21(1a): 39-44
Wu, M-Jei.; Fang, H-Chang.; Chang, T-Yuan.; Lo, Y-Shing.; Chung, H-Min. 2002: Multiple myeloma with myeloma nephropathy in a patient with Hashimoto's thyroiditis Journal of the Formosan Medical Association 101(6): 421-424
García Laraña, J.; Díaz Mediavilla, J.; Martínez, R.; Lahuerta, J.J.; Alegre, A.; Odriozola, J.; Sureda, A.; San Miguel, J.; De la Rubia, J.; Escudero, A.; Conde, E.; Bladé, J.; Cabrera, R.; Gastearena, J.; Besalduch, J.; Vidal, M.J.; Hernández, F.; Rifon, J.; Leon, A.; Mataix, R.; Parody, R.; Moraleda, J.M.; Solano, C.; de Pablos, J.M.; Sánchez, J.J. 1997: Maintenance treatment with interferon-alfa in multiple myeloma after autotransplantation of peripheral blood progenitor cells. Spanish Register of Transplantation in Myeloma Sangre 42(Suppl 1): 38-41
Teunissen, L.L.; Notermans, N.C. 1998: The risk of Kahler disease (multiple myeloma) in patients with a paraproteinemia: myeloma risk score, developed in the region of the Integral Cancer Center, West Nederlands Tijdschrift Voor Geneeskunde 142(43): 2374-2375
Takahashi, T.; Makiguchi, Y.; Hinoda, Y.; Kakiuchi, H.; Nakagawa, N.; Imai, K.; Yachi, A. 1994: Expression of MUC1 on myeloma cells and induction of HLA-unrestricted CTL against MUC1 from a multiple myeloma patient Journal of Immunology 153(5): 2102-2109
Ohashi, K. 2002: MTP inhibitors and ACAT inhibitors. An update Nihon Rinsho. Japanese Journal of Clinical Medicine 60(5): 975-983
Jacobs, P.B. 1987: Myeloma update South African Medical Journal 71(4): 206-208
Subbarao, V.; Phillips, J.; Stouffer, G.A. 1998: Update on glycoprotein IIb/IIa inhibitors Idrugs: the Investigational Drugs Journal 1(6): 668-674